Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Biomarker”

3,006 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,006 results

Not applicableLooking for participantsNCT03237702
What this trial is testing

Decipher Lethal Prostate Cancer Biology - Urine Metabolomics

Who this might be right for
Significant Prostate Cancer
National Taiwan University Hospital 2,000
Not applicableStudy completedNCT01208467
What this trial is testing

Prognostic Biomarkers in Patients With Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group 2,824
Not applicableTemporarily pausedNCT05233007
What this trial is testing

Upper GI Serial Tumour Biopsies

Who this might be right for
Oesophageal CancerGastric Cancer
The Christie NHS Foundation Trust 300
Not applicableLooking for participantsNCT02102165
What this trial is testing

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer
Breast International Group 1,000
Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Testing effectiveness (Phase 2)UnknownNCT04152057
What this trial is testing

Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

Who this might be right for
Breast CancerHER2 PositiveCombination Chemotherapy
West China Hospital 20
Not applicableNot Yet RecruitingNCT07253077
What this trial is testing

Evaluation of Cardiac and Endothelial Function in Children and Adolescents Treated With Anthracycline

Who this might be right for
Anthracycline Related Cardiotoxicity in Childhood CancersChemotherapeutic ToxicityChildhood Cancer Survivors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Not applicableStudy completedNCT04776837
What this trial is testing

Predicting Disease Progression and/or Recurrence in Cancer

Who this might be right for
Patient Reported Outcome MeasuresColorectal CancerPancreatic Cancer+5 more
Massachusetts General Hospital 200
Not applicableLooking for participantsNCT06085781
What this trial is testing

Head and Neck MRI and Tumor Microenvironment Biomarkers

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
University Health Network, Toronto 60
Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Not applicableUnknownNCT01860508
What this trial is testing

PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

Who this might be right for
Non-small Cell Lung Cancer
Fudan University 94
Testing effectiveness (Phase 2)Study completedNCT00052611
What this trial is testing

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334
What this trial is testing

Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 39
Very early researchWithdrawnNCT02774512
What this trial is testing

Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer

Who this might be right for
Colon Cancer
Institut Bergonié
Not applicableStudy completedNCT04448730
What this trial is testing

Polycystic Ovary Syndrome and BETATROPHIN

Who this might be right for
Polycystic OvaryObesity
Hatice Akkaya 73
Not applicableLooking for participantsNCT06863844
What this trial is testing

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

Who this might be right for
Urothelial Neoplasm
IRCCS Azienda Ospedaliero-Universitaria di Bologna 210
Early research (Phase 1)Active Not RecruitingNCT04975152
What this trial is testing

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT07510828
What this trial is testing

PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Beijing Biotech 60
Not applicableStudy completedNCT00665067
What this trial is testing

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

Who this might be right for
Myeloproliferative DiseaseMyelofibrosisIdiopathic Myelofibrosis+2 more
Icahn School of Medicine at Mount Sinai 592
Not applicableStudy completedNCT03259230
What this trial is testing

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum 40
Load More Results